Clinical outcome of central conventional chondrosarcoma

Andrea Angelini, Giovanni Guerra, Andreas F. Mavrogenis, Elisa Pala, Piero Picci, Pietro Ruggieri

Research output: Contribution to journalArticle

68 Citations (Scopus)

Abstract

Introduction Aim of this study was to analyze (1) survival, local recurrence (LR), and metastasis rates between the three histological tumor grades; (2) whether type of treatment and tumor site influenced prognosis for each histologic grade. Methods We retrospectively studied 296 patients with central conventional chondrosarcomas (CS) (87 grade 1, 162 grade 2, and 47 grade 3). The femur was the most common site (91 cases), followed by the pelvis (82) and other less frequent sites. Type of surgery was related with histologic grade. Margins were wide in 222 cases, marginal in 23, and intralesional in 51 cases. Results At a mean of 7 years, 201 patients remained continuously NED, 33 were NED after treatment of relapse, 15 were AWD, 35 were died of disease, and 12 of other causes. Survival was 92% at 5 years and 84% at 10 years, significantly influenced by histological grading. In grade 3 CS, two factors influenced survival: type of surgery (resection vs. amputation, P = 0.051) and site (P = 0.039). The two significant factors lost their significance at multivariate analysis. Conclusion Central conventional CS with low/intermediate grade has a good prognosis, while high-grade tumors have poor outcome. Tumor relapses are strictly related with histologic grade.

Original languageEnglish
Pages (from-to)929-937
Number of pages9
JournalJournal of Surgical Oncology
Volume106
Issue number8
DOIs
Publication statusPublished - Dec 2012

Fingerprint

Chondrosarcoma
Recurrence
Neoplasms
Survival
Survival Analysis
Pelvis
Amputation
Femur
Multivariate Analysis
Neoplasm Metastasis
Therapeutics

Keywords

  • chondrosarcoma
  • clinical outcome
  • grade
  • prognostic factors
  • surgical treatment

ASJC Scopus subject areas

  • Surgery
  • Oncology

Cite this

Angelini, A., Guerra, G., Mavrogenis, A. F., Pala, E., Picci, P., & Ruggieri, P. (2012). Clinical outcome of central conventional chondrosarcoma. Journal of Surgical Oncology, 106(8), 929-937. https://doi.org/10.1002/jso.23173

Clinical outcome of central conventional chondrosarcoma. / Angelini, Andrea; Guerra, Giovanni; Mavrogenis, Andreas F.; Pala, Elisa; Picci, Piero; Ruggieri, Pietro.

In: Journal of Surgical Oncology, Vol. 106, No. 8, 12.2012, p. 929-937.

Research output: Contribution to journalArticle

Angelini, A, Guerra, G, Mavrogenis, AF, Pala, E, Picci, P & Ruggieri, P 2012, 'Clinical outcome of central conventional chondrosarcoma', Journal of Surgical Oncology, vol. 106, no. 8, pp. 929-937. https://doi.org/10.1002/jso.23173
Angelini A, Guerra G, Mavrogenis AF, Pala E, Picci P, Ruggieri P. Clinical outcome of central conventional chondrosarcoma. Journal of Surgical Oncology. 2012 Dec;106(8):929-937. https://doi.org/10.1002/jso.23173
Angelini, Andrea ; Guerra, Giovanni ; Mavrogenis, Andreas F. ; Pala, Elisa ; Picci, Piero ; Ruggieri, Pietro. / Clinical outcome of central conventional chondrosarcoma. In: Journal of Surgical Oncology. 2012 ; Vol. 106, No. 8. pp. 929-937.
@article{928f4741015a436ab705014bbbac79f2,
title = "Clinical outcome of central conventional chondrosarcoma",
abstract = "Introduction Aim of this study was to analyze (1) survival, local recurrence (LR), and metastasis rates between the three histological tumor grades; (2) whether type of treatment and tumor site influenced prognosis for each histologic grade. Methods We retrospectively studied 296 patients with central conventional chondrosarcomas (CS) (87 grade 1, 162 grade 2, and 47 grade 3). The femur was the most common site (91 cases), followed by the pelvis (82) and other less frequent sites. Type of surgery was related with histologic grade. Margins were wide in 222 cases, marginal in 23, and intralesional in 51 cases. Results At a mean of 7 years, 201 patients remained continuously NED, 33 were NED after treatment of relapse, 15 were AWD, 35 were died of disease, and 12 of other causes. Survival was 92{\%} at 5 years and 84{\%} at 10 years, significantly influenced by histological grading. In grade 3 CS, two factors influenced survival: type of surgery (resection vs. amputation, P = 0.051) and site (P = 0.039). The two significant factors lost their significance at multivariate analysis. Conclusion Central conventional CS with low/intermediate grade has a good prognosis, while high-grade tumors have poor outcome. Tumor relapses are strictly related with histologic grade.",
keywords = "chondrosarcoma, clinical outcome, grade, prognostic factors, surgical treatment",
author = "Andrea Angelini and Giovanni Guerra and Mavrogenis, {Andreas F.} and Elisa Pala and Piero Picci and Pietro Ruggieri",
year = "2012",
month = "12",
doi = "10.1002/jso.23173",
language = "English",
volume = "106",
pages = "929--937",
journal = "Journal of Surgical Oncology",
issn = "0022-4790",
publisher = "John Wiley and Sons Inc.",
number = "8",

}

TY - JOUR

T1 - Clinical outcome of central conventional chondrosarcoma

AU - Angelini, Andrea

AU - Guerra, Giovanni

AU - Mavrogenis, Andreas F.

AU - Pala, Elisa

AU - Picci, Piero

AU - Ruggieri, Pietro

PY - 2012/12

Y1 - 2012/12

N2 - Introduction Aim of this study was to analyze (1) survival, local recurrence (LR), and metastasis rates between the three histological tumor grades; (2) whether type of treatment and tumor site influenced prognosis for each histologic grade. Methods We retrospectively studied 296 patients with central conventional chondrosarcomas (CS) (87 grade 1, 162 grade 2, and 47 grade 3). The femur was the most common site (91 cases), followed by the pelvis (82) and other less frequent sites. Type of surgery was related with histologic grade. Margins were wide in 222 cases, marginal in 23, and intralesional in 51 cases. Results At a mean of 7 years, 201 patients remained continuously NED, 33 were NED after treatment of relapse, 15 were AWD, 35 were died of disease, and 12 of other causes. Survival was 92% at 5 years and 84% at 10 years, significantly influenced by histological grading. In grade 3 CS, two factors influenced survival: type of surgery (resection vs. amputation, P = 0.051) and site (P = 0.039). The two significant factors lost their significance at multivariate analysis. Conclusion Central conventional CS with low/intermediate grade has a good prognosis, while high-grade tumors have poor outcome. Tumor relapses are strictly related with histologic grade.

AB - Introduction Aim of this study was to analyze (1) survival, local recurrence (LR), and metastasis rates between the three histological tumor grades; (2) whether type of treatment and tumor site influenced prognosis for each histologic grade. Methods We retrospectively studied 296 patients with central conventional chondrosarcomas (CS) (87 grade 1, 162 grade 2, and 47 grade 3). The femur was the most common site (91 cases), followed by the pelvis (82) and other less frequent sites. Type of surgery was related with histologic grade. Margins were wide in 222 cases, marginal in 23, and intralesional in 51 cases. Results At a mean of 7 years, 201 patients remained continuously NED, 33 were NED after treatment of relapse, 15 were AWD, 35 were died of disease, and 12 of other causes. Survival was 92% at 5 years and 84% at 10 years, significantly influenced by histological grading. In grade 3 CS, two factors influenced survival: type of surgery (resection vs. amputation, P = 0.051) and site (P = 0.039). The two significant factors lost their significance at multivariate analysis. Conclusion Central conventional CS with low/intermediate grade has a good prognosis, while high-grade tumors have poor outcome. Tumor relapses are strictly related with histologic grade.

KW - chondrosarcoma

KW - clinical outcome

KW - grade

KW - prognostic factors

KW - surgical treatment

UR - http://www.scopus.com/inward/record.url?scp=84869492290&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84869492290&partnerID=8YFLogxK

U2 - 10.1002/jso.23173

DO - 10.1002/jso.23173

M3 - Article

VL - 106

SP - 929

EP - 937

JO - Journal of Surgical Oncology

JF - Journal of Surgical Oncology

SN - 0022-4790

IS - 8

ER -